Meet the Precision
AQ team at
World EPA Congress
Amsterdam, Netherlands | March 3-4, 2026
Precision AQ is a commercialization partner for biopharma innovators, market access teams, and brand strategists. Working with clients from all 30 of the world’s top pharma companies, we specialize in turning data chaos into commercial clarity.
Whether it’s building the right evidence or refining your value story, we’re here to simplify the journey from development to patient care – so your therapies can reach the patients who need them most.
Our International Access Consulting team supports global launch and commercialization strategies across diverse markets and regulatory landscapes, delivering tailored insights on value, pricing, reimbursement, and access dynamics that align evidence with the expectations of global decision makers. Our HEOR experts quantify value in ways that resonate with payers, providers, and policymakers by building models, analyses, and evidence frameworks that demonstrate clinical, economic, and societal impact. Together, these capabilities strengthen value narratives and equip teams for confident, evidence‑driven decision‑making.
Complete the form to book a meeting, and we’ll reach out to confirm the details.
The New Avenue for Access? European Market Access Routes Outside Traditional Public Payer Pathways
Richard Macaulay, PhD; David Carr, PhD; Sam Coates, Ethan Prince, MSc
Japan’s FY2026 Drug Pricing Reform: Policy Changes and Pricing Implications
Rebecca Andrews, MChem; Dominika Meszarosova, MSc
Chloe Wang, MSc; Dominika Meszarosova, MSc
Vrushti Mavani; Dimitrios Tzaras, MSc; Richard Macaulay, PhD
Sean Markwardt, PhD | SVP, Growth Optimization, Medical Communications
Janet Serluco | SVP, Access Experience Team Oncology Lead Madeline Waldron, PharmD, BCOP | Vice President, Oncology...
David Carr, PhD | Vice President, Global Pricing & Market Access Mary Wake | Engagement Manager, Global Pricing &...